Kissire Deborah J. reported grant involving 5.709 derivative units of Celanese Corp at $48.93 for $279 on Nov 10, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$279.34Shares × reported price
Shares traded
5.709Phantom Stock
Price per share
$48.93Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
9,315.763Direct
Trade date
Nov 10, 2026Grant
Filed
Nov 12, 2026, 4:40 PM ET2-day reporting delay
Accession
0001648794-26-000006Code A · Transaction 399188
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CE price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CE · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.9%1w ago −7.9%1d ago −7.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: Each share of phantom stock represents the right to receive one share of Common Stock. F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.